XClose

UCL Therapeutic Innovation Networks

Home
Menu

UCL Drug Discovery & Development Therapeutic Symposium: Novel & Repurposed

14 July 2022, 12:00 pm–7:00 pm

Drug Discovery and Development Therapeutic Symposium banner

This Drug Discovery & Development Therapeutic Symposium will be a showcase & networking event for Small Molecules & Drug Repurposing at UCL.

Event Information

Open to

All

Availability

Yes

Organiser

Alina Shrourou

Location

UCL School of Pharmacy
29-39 Brunswick Square
London
WC1N 1AX

The UCL Translational Research Office (TRO) are pleased to be hosting the first in-person Therapeutic Innovation Networks (TINs) event since January 2020!

The symposium aims to follow the journey from drug discovery to therapeutic development, providing an overview of our strengths and capabilities in novel and repurposed therapeutics, as well as celebrating achievements and recognising successful researchers in the field from across the university and at all career stages. We hope that by gathering drug discovery and development experts from UCL, partner hospitals, Industry, Funders and wider, we can facilitate meaningful multidisciplinary translational opportunities and establish innovative partnerships to lead the future of therapeutic drug discovery and development at UCL.

This event is open to all, including external, non-UCL attendees.

If you are a UCL attendee, including partner NHS organisations, please note the event is free. To confirm authenticity of your registration, please use your UCL/NHS email address when registering.

If you are an external partner and would like to attend as a non-UCL attendee, please contact Alina Shrourou (a.shrourou@ucl.ac.uk) as soon as possible as places are limited in availability.

Programme overview (12-7pm)

Session 1

1.35pm - Drug Discovery and Development at UCL (Dr Jane Kinghorn)

1.45pm - Early Career Innovator Presentations (Small Molecules TIN Pilot Data Scheme 2020 awardees)

2.35pm - Break and Poster Presentation

Session 2

3.15pm - Early Career Innovator Presentations (Repurposing TIN Pilot Data Scheme 2020 awardees)

4.15pm - Open Antiviral Drug Discovery for the Next Pandemic (Professor Matthew Todd)

4.25pm - Melatonin for the treatment of birth asphyxia (Professor Nikki Robertson)

4.45pm - Accelerating Drug Discovery - Alzheimer's Research UK Drug Discovery Institute (Dr Sarah Jolly, ARUK DDI and Dr Jamie Bilsland, AstronauTx)

4.55pm - Drug Discovery Roadmap at UCL (Professor Oscar Della Pasqua)

5:05pm - Poster Prize Presentation from the UCL President & Provost (Dr Michael Spence)

5.15pm - Closing Remarks (Professor Alan Thompson)

5.25pm - Networking and Drinks Reception

View the full, detailed programme.

Poster Submission

We are providing UCL researchers an opportunity to showcase active drug discovery and development activity by presenting a poster. Due to limited availability, poster presentation opportunities are provided on a first come, first served basis. You will be notified by Thursday 16th June if your poster has been accepted.

There will be a prize for the best research poster. All research posters submitted will be considered and will be required to present to a panel to be judged on the day. More details will be given closer to the event.

Please note the following details to ensure you submit correctly:

  • Please submit your posters while registering online for this event. No posters will be accepted on the day that have not been submitted in advance.
  • All poster details must be complete at time of registration, you will not be able to add information to your submission once you have completed registration.
  • The non-confidential poster must be submitted under one of the following categories: Discovery & Development; Preclinical Research; Preclinical Development; Clinical Evaluation; Regulatory Review and Marketing Approval; Post-Market Monitoring; Enabling Technologies and Platforms. More information regarding what activity is included under these headings can be found here.
  • Details required for submission on registration are: Poster Category; Project Remit; Stage of Drug Discovery; Disease Area; Poster Title, Poster Authors, Poster Abstract (200 words). More information on this can be found here.
  • The deadline for poster submission is Thursday 9th June 2022. All poster submitters will be notified by Thursday 16th June of acceptance.
  • A0 size posters, portrait in orientation, are required for presentation.

Registration link for attendance and poster submission